TITLE

Caution needed for Russian Expansion

PUB. DATE
July 2006
SOURCE
Pharmaceutical Technology Europe;Jul2006, Vol. 18 Issue 7, p10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article indicates that accounting and consulting firm PricewaterhouseCoopers has released a report on the opportunities and problems associated with the pharmaceutical industry in Russia. It was observed that the legal system is much weaker than in the European Union, U.S. or Japan, and that establishing intellectual property protection is much more difficult.
ACCESSION #
21877676

 

Related Articles

  • Intellectual property, pharmaceutical MNEs and the developing world. Ghauri, Pervez N.; Rao, P.M. // Journal of World Business;Apr2009, Vol. 44 Issue 2, p206 

    Abstract: The paper examines the structure of pharmaceutical R&D funding, spillovers and public�private-academic research linkages in the developing countries. The paper also examines several policy options aimed at mitigating the trade off between the twin and often conflicting objectives...

  • Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity. Morag-Sela, Tamar; Cohn, Ilan; Kowalski, Thomas J.; Jarecki-Black, Judy; Clyde-Watson, Zoe // Nature Biotechnology;Dec2004, Vol. 22 Issue 12, p1591 

    The article discusses issues related to intellectual property (IP) rights to pharmaceuticals in Israel. The country has a very strong generic pharmaceutical industry. Israel's past record of defending and respecting IP rights has led major companies around the world to file patent applications...

  • Governments Can Help Piracy Fight, Companies Say. Heffes, Ellen M.; Marshall, Jeffrey // Financial Executive;May2007, Vol. 23 Issue 4, p11 

    The article discusses a survey by the International Chamber of Commerce and London's Cass Business School that reveals global companies believe that more government enforcement of intellectual property law is need to win the fight against counterfeiting and piracy. The survey, which was entitled...

  • Why are the Multinational Franchisors not Franchising in China? Sinclair, James A. C.; Xiong, Linda // European Retail Digest;Fall2006, Issue 51, p57 

    The article discusses the factors that influence multinational franchisors not to franchise in China. Sales revenue from franchise systems in the country represents only 3% of total retail sales compared to an average of 40% in developed markets. The country's basic legal framework for franchise...

  • Migration of UK Corporates: an Emerging Trend.  // Venulex Legal Summaries;2008 Q2, Special section p1 

    The article deals with the increase of British multinationals that are considering migrating their tax residency. Relocation of a holding company outside Great Britain will not reduce the overall British tax burden of an organization in the short term without the relocation of functions and...

  • Location advantages and subsidiaries’ R&D activities in emerging economies: Exploring the effect of employee mobility. Yang, Qin; Jiang, Crystal // Asia Pacific Journal of Management;Sep2007, Vol. 24 Issue 3, p341 

    With multinational corporations increasingly seeking subsidiaries’ specific advantages in foreign countries to develop their innovative capabilities, internationalization of research and development has been greatly emphasized. However, in emerging economies, managers are encountering the...

  • KEY KNOWLEDGE AND COMPETENCES IN THE EUROPEAN AND INTERNATIONAL BUSINESS LAW - ACADEMIA PERSPECTIVE. Kittová, HSG Zuzana // International Multidisciplinary Scientific Conference on Social ;2015, p573 

    The paper is a part of a broader research aimed at identifying and evaluating key knowledge and competences in the European and international business law of graduates in International Business in the Slovak Republic. In Slovakia, several studies have been carried out in the field of university...

  • Can You Keep a Secret? Richmond, Rick; Caslin, Brent // Pharmaceutical Executive;Apr2004, Vol. 24 Issue 4, p58 

    Describes how a pharmaceutical company can protect itself under civil trade secret laws in the United States. Key component in a company's strategy to protect its intellectual property; Implementing thoughtful and clear policies about the receipt and use of confidential information; Rules that...

  • TRIPS COMPLIANCE: DEALING WITH THE CONSEQUENCES OF DRUG PATENTS IN INDIA. Gupta, Rishi // Houston Journal of International Law;Spring2004, Vol. 26 Issue 3, p599 

    Discusses the implications of India's compliance with the Trade Related Aspects of Intellectual Property Rights agreement. Role in promoting research into diseases such as malaria and tuberculosis; Impact on the generic drugs manufacturers and the Indian pharmaceutical industry in general;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics